Clinical Trial Update: Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the analgesic potential of the (2R,6R)-hydroxynorketamine in acute pain using healthy volunteers, with recruitment no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• (2R,6R)-HNK (2R,6R-hydroxynorketamine)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Pain, Healthy Volunteers | Phase 2 | Status: NOT_YET_RECRUITING